Prospective study comparing between the effects of fibrinogen concentrate, and rFVIIa on reduction of blood products transfusion requirements in elective CABG

Not Applicable

• Conditions: Circulatory System; Haematological Disorders

• Registration Number: PACTR201901535105039
• Lead Sponsor: Ain Shams University Hospitals

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-20
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients scheduled coronary artery bypass grafting (CABG)
persistent clinical evidence of bleeding, after heparin reversal, requiring hemostatic therapy, as assessed by anesthetist.

Exclusion Criteria

Patients with previous cardiac surgery,
patients with previous history of coagulopathy or thromboembolic manifestations.
Patients with history of stroke.

Study & Design

• Study Type: Interventional
• Study Design: Not specified